2023. Impact of Actinic Keratosis (AK), as measured by patient-reported AK symptoms, and impact on emotions and functioning (using Skindex-16) among patients with AK administered tirbanibulin in real-world community practices across the U.S. (PROAK Study). SKIN The Journal of Cutaneous Medicine. 7, 2 (Mar. 2023), s161. DOI:https://doi.org/10.25251/skin.7.supp.161.